Targeted Metabolomics and Spent Embryo Culture Medium
Launched by GYN-MEDICUM GÖTTINGEN · Oct 16, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the nutrients and chemicals in the fluid that embryos are grown in (called spent embryo culture medium, or SECM) can help us understand and improve embryo development during in vitro fertilization (IVF). The researchers want to find out if measuring the metabolic profiles—essentially the "nutritional fingerprints"—of this fluid can provide important information about how embryos are growing. By combining these measurements with traditional ways of looking at embryos (morphology), they hope to create a more personalized approach to embryo care, tailoring the growth environment based on specific needs of the embryos.
To participate in this study, women aged 12 to 40 who have given informed consent and have available SECM samples may be eligible. However, individuals with diabetes cannot take part. If you join the trial, you can expect to contribute to important research that could lead to better IVF outcomes in the future. Your participation could help us learn more about how to nurture embryos effectively, ultimately improving chances for successful pregnancies.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • - Available spent embryo culture medium (SECM) samples with Informed consent
- Exclusion Criteria:
- • Diabetes
About Gyn Medicum Göttingen
Gyn-Medicum Göttingen is a specialized clinical trial sponsor focused on advancing women's health through innovative research and development. With a commitment to improving medical outcomes, Gyn-Medicum Göttingen conducts rigorous clinical trials that evaluate new therapies and interventions in gynecology and obstetrics. Leveraging a multidisciplinary team of experienced professionals, the organization prioritizes patient safety and ethical standards while fostering collaboration with healthcare providers and regulatory bodies. Through its extensive expertise and dedication to evidence-based practices, Gyn-Medicum Göttingen aims to contribute significantly to the field of women's health and enhance the quality of life for patients globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Göttingen, Niedersachsen, Germany
Patients applied
Trial Officials
Andreas Schmutzler, PD Dr. med.
Study Chair
gyn-medicum Göttingen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported